In vitro and in vivo effects of clove on pro-inflammatory cytokines production by macrophages

Natural Product Research

Volumn 23, Issue 4, 2009, Pages 319-326

  Rodrigues, T G ^a   Fernandes Jr , A ^a   Sousa, J P B ^b   Bastos, J K ^b   Sforcin, J M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clove; Cytokines; Essential oil; Macrophages

Indexed keywords

CLOVE EXTRACT; CLOVE OIL; ESSENTIAL OIL; EUGENOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER; CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CLOVE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SPICE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUGENIA; MACROPHAGE; METABOLISM;

MUS; SYZYGIUM AROMATICUM;

ANIMALS; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUGENIA; EUGENOL; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; OILS, VOLATILE; PLANT EXTRACTS;

EID: 65549117994     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410802242679     Document Type: Article

References (27)

1. Adams, R.P. (2001). Identification of essential oil components by gas chromatography quadupole mass spectroscopy. Carol Stream: Allure Publishing Corporation.
2. Ahn, K.Y., Kim, B.H., Lee, Y.R., Hwang, D.H., Chung, E.Y., Min, K.R., et al. (2005). Dual inhibitory effects of furonaphtoquinone compound on enzyme activity and lipopolysaccharide-induced expression of cyclooxygenase-2 in macrophages. Biochemical and Biophysical Research Communications, 336, 93-99.
3. Banerjee, S., Panda, C.K., & Das, S. (2006). Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis, 27, 1645-1654. (Pubitemid 44288054)
4. Betoni, J.E., Mantovani, R.P., Barbosa, L.N., Di Stasi, L.C., & Fernandes, A. Jr (2006). Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Memórias do Instituto Oswaldo Cruz, 101, 387-390.
5. Cai, L., & Wu, C.D. (1996). Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens. Journal of Natural Products, 59, 987-990. (Pubitemid 26365498)
6. Cheng, A., Wan, F., Wang, J., Jin, Z., & Xu, X. (2008). Macrophage immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis fish. International Immunopharmacology, 8, 43-50. (Pubitemid 350199716)
7. Ghelardini, C., Galeotti, N., Mannelli, L.D.C., Mazzanti, G., & Bartolini, A. (2001). Local anaesthetic activity of β-caryophyllene. Il Farmaco, 56, 387-389.
8. Kamimura, D., Ishihara, K., & Hirano, T. (2003). IL-6 signal transduction and its physiological roles: Thesignal orchestration model. Reviews of Physiology Biochemistry and Pharmacology,149,1-38.
9. Kim, H.M., Lee, E.H., Hong, S.H., Song, H.J., Shin, M.K., Kim, S.H., et al. (1998). Effect of Syzygium aromaticum extract on immediate hypersensitivity in rats. Journal of Ethnopharmacology, 60, 125-131.
10. Lamm, D.L., & Riggs, D.R. (2001). Enhanced immunocompetence by garlic: Role in bladder cancer and other malignancies. The British Journal of Nutrition, 131, 1067S-1670S.
11. Lee, K.G., & Shibamoto, T. (2001). Inhibtion of malonaldehyde formation from blood plasma oxidation by aroma extract and aroma components isolated from clove and eucalyptus. Food and Chemical Toxicology, 39, 1199-1204.
12. Lee, Y.Y., Yang, S.F., Ho, W.H., Lee, Y.H., & Hung, S.L. (2007). Eugenol modulates cyclooxygenase-2 expression through the activation of nuclear factor kappa B in human osteoblasts. Journal of Endodontics, 33, 1177-1182.
13. Missima, F., Silva Filho, A.A., Nunes, G.A., Bueno, P.C., Sousa, J.P., Bastos, J.K., et al. (2007). Effect of Baccharis dracunculifolia D.C. (Asteraceae) extracts and its isolated compounds on macrophage activation. Journal of Pharmacy and Pharmacology, 59, 463-468. (Pubitemid 47050912)
14. Moriyasu, J., Arai, S., Motoda, R., & Kurimoto, M. (1994). In vitro activation of mouse macrophage by propolis extract powder. Biotherapy, 8, 364-365.
15. Park, K.R., Lee, J.H., Choi, C.Y., Liu, K.H., Seog, D.H., Kim, Y.H., et al. (2007). Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-κB. International Immunopharmacology, 7, 1251-1258. (Pubitemid 47042642)
16. Pawar, V.C., & Thaker, V.S. (2006). In vitro efficacy of 75 essential oils against Aspergillus niger. Mycoses, 49, 316-323.
17. Pope, R.M., & Tschopp, J. (2007). The role of interleukin-1 and the inflammasome in gout: Implications for therapy. Arthritis and Rheumatism, 56, 3183-3188. (Pubitemid 47585412)
18. Sandur, S.K., Ichikawa, H., Sethi, G., Ahn, K.S., & Aggarwal, B.B. (2006). Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. Journal of Biological Chemistry, 281, 17023-17033. (Pubitemid 43909506)
19. Sforcin, J.M. (2007). Propolis and the immune system: A review. Journal of Ethnopharmacology, 113, 1-14.
20. Sforcin, J.M., Kaneno, R., & Funari, S.R.C. (2002). Absence of seasonal effect on the immunomodulatory action of Brazilian propolis on natural killer activity. The Journal of Venomous Animals and Toxins, 8, 19-29.
21. Sforcin, J.M., Nunes, G.A., Missima, F., Sá-Nunes, A., & Faccioli, L.H. (2007). Effect of a leukotriene inhibitor (MK886) on nitric oxide and hydrogen peroxide production by macrophages of acutely and chronically stressed mice. Journal of Pharmacy and Pharmacology, 59, 1249-1254. (Pubitemid 47359904)
22. Sforcin, J.M., Orsi, R.O., & Bankova, V. (2005). Effects of propolis, some isolated compounds and its source plant on antibody production. Journal of Ethnopharmacology, 98, 301-305.
23. Shin, H.M., Lee, Y.R., Chang, Y.S., Lee, J.Y., Kim, B.H., Min, K.R., et al. (2006). Suppression of interleukin-6 production in macrophages by furonaphthoquinone NFD-37. International Immunopharmacology, 6, 916-923.
24. Sieben, S., Hertl, M., Masaoudi, T.A., Merck, H.F., & Blomeke, B. (2001). Characterization of T cell responses to fragrances. Toxicology and Applied Pharmacology, 172, 172-178.
25. Tan, E.L., Selvaratnam, G., Kananathan, R., & Sam, C.K. (2006). Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-β1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer, 6, 227. (Pubitemid 44541831)
26. Tzeng, H.P., Ho, F.M., Chao, K.F., Kuo, M.L., Lin-Shiau, S.Y., & Liu, S.H. (2003). β-lapachone reduces endotoxin-induced macrophage activation and lung edema and mortality. American Journal of Respiratory and Critical Care Medicine, 168, 85-91.
27. Zar, J.H. (1999). Biostatistical analysis (4th ed.). New Jersey: Prentice Hall.